Success Stories: A Postdoctoral Researcher from China Has Two Petition Approvals (NIW & EB1A) with the Help of Our Aiding Team Members

 

Client’s Testimonial:

“Thank you so much for your help! The excellent and outstanding professionalism, friendliness, and suggestions of your attorney team helped me quickly meet the NIW and EB1A requirements. I am very willing to recommend your team to all people in need.”


On April 22nd, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Researcher in the Field of Immunology (Approval Notice).


General Field: Immunology

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: China

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: April 22nd, 2021

Processing Time: 6 months, 13 days


Case Summary:

A postdoctoral researcher from China, holding a Ph.D. in immunology, engaged us to compose an NIW (National Interest Waiver) petition back in 2020. While his NIW case was pending, he decided to file another petition under the EB-1A (Alien of Extraordinary Ability) visa category on his behalf. As a part of our legal strategy, we incorporated the required and relevant documents to get him to achieve the EB1A approval. Based on the abundance of information we gathered, we ascertained our client’s research knowledge, expertise in the immunology field, and past achievements, validating his extraordinary ability to extend his research work here in the United States. Thus, we countersigned the retainer agreement and began preparing his petition presentation, highlighting his extraordinary skills in the field:

  • We described his research on new targeted cell therapy methods and how it addresses some of our nation’s most pressing issues, including the enormous and increasing burden of cancer and neurodegenerative disease.
  • Also, we noted the 17 peer-reviewed scientific articles published by him in some of the discerning journals, confirming his work is considered majorly significant by the editors of the top journals in his chosen field. Further, we recorded that editor of these highly acclaimed journals with very stringent publishing guidelines enlist the services of only the most accomplished researchers. They exercise utmost care when selecting experts to conduct peer review to ensure that the papers they publish address meaningful research questions and arrive at valid, verifiable conclusions. Thus, his peer-review contributions 24 times, verifies that he meets this criterion.
  • In addition, we detailed the 307 citations, coming from independent and leading researchers from preeminent institutions around the world, indicating the major significance of his work, which has been cited by researchers in at least 32 countries.
  • Moreover, we attached four recommendation letters in his case to support the petition further. They confirmed how our client’s research is fundamentally increasing our ability to fight neurological diseases, and it is highly valuable to global public health. One of the recommenders also stated:

“To provide an enhanced quality of life and chance of survival for the hundreds of thousands of people who suffer from these diseases around the world, as well as to bolster the increasingly lucrative T cell therapy market, the continuation of [client’s] research is globally necessary.”

We successfully convinced the USCIS that our client’s research is majorly influential to the United States, therefore, our client achieved his EB-1A approval just after 2 months of his NIW approval, bringing him one big step closer to securing a green card. We thank him for choosing us to represent his I-140 applications and for allowing us to have a significant role in this successful journey.